Allogene Therapeutics Plans to Attend Three Investor Conferences

PUBT · 2d ago
Allogene Therapeutics Plans to Attend Three Investor Conferences
  • Allogene Therapeutics to attend UBS Global Biopharma Conference in London Nov. 16, 2026, at 11:20 a.m. GMT / 6:20 a.m. ET.
  • Participation in Jefferies Global Healthcare Conference in London scheduled for Nov. 18, 2026, at 9:30 a.m. GMT / 5:30 a.m. ET.
  • Piper Sandler 38th Annual Healthcare Conference appearance set for Dec. 2, 2026, in New York.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allogene Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610260830PRIMZONEFULLFEED9852473) on October 26, 2026, and is solely responsible for the information contained therein.